Wordt geladen...
Oral melphalan as a treatment for platinum-resistant ovarian cancer
A large number of drugs have been used to treat recurrent ovarian cancer, yet there are few data that guide the physician's choice. Typically, the decision to re-treat with platinum-based therapy depends on the progression-free interval. However, the optimum agent for the treatment of platinum-...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2003
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2741128/ https://ncbi.nlm.nih.gov/pubmed/12799622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601044 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|